<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">23406779</PMID>
      <DateCompleted>
        <Year>2013</Year>
        <Month>09</Month>
        <Day>20</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2150-5608</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>4</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2013</Year>
              <Month>Apr</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Virulence</Title>
          <ISOAbbreviation>Virulence</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Resistance mechanisms in Campylobacter jejuni.</ArticleTitle>
        <Pagination>
          <StartPage>230</StartPage>
          <EndPage>240</EndPage>
          <MedlinePgn>230-40</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.4161/viru.23753</ELocationID>
        <Abstract>
          <AbstractText>Campylobacter jejuni is a major cause of food-borne gastroenteritis worldwide. While mortality is low, morbidity imparted by post-infectious sequelae such as Guillain-Barré syndrome, Reiter syndrome/reactive arthritis and irritable bowel syndrome is significant. In addition, the economic cost is high due to lost productivity. Food animals, particularly poultry, are the main reservoirs of C. jejuni. The over-use of antibiotics in the human population and in animal husbandry has led to an increase in antibiotic-resistant infections, particularly with fluoroquinolones. This is problematic because C. jejuni gastroenteritis is clinically indistinguishable from that caused by other bacterial pathogens, and such illnesses are usually treated empirically with fluoroquinolones. Since C. jejuni is naturally transformable, acquisition of additional genes imparting antibiotic resistance is likely. Therefore, an understanding of the antibiotic resistance mechanisms in C. jejuni is needed to provide proper therapy both to the veterinary and human populations.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Iovine</LastName>
            <ForeName>Nicole M</ForeName>
            <Initials>NM</Initials>
            <AffiliationInfo>
              <Affiliation>University of Florida and the Malcom Randall VA Medical Center, Gainesville, FL, USA. iovinnm@medicine.ufl.edu</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2013</Year>
          <Month>02</Month>
          <Day>13</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Virulence</MedlineTA>
        <NlmUniqueID>101531386</NlmUniqueID>
        <ISSNLinking>2150-5594</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002169" MajorTopicYN="N">Campylobacter Infections</DescriptorName>
          <QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName>
          <QualifierName UI="Q000662" MajorTopicYN="Y">veterinary</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016123" MajorTopicYN="N">Campylobacter jejuni</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D024881" MajorTopicYN="Y">Drug Resistance, Bacterial</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Campylobacter jejuni</Keyword>
        <Keyword MajorTopicYN="N">CmeABC</Keyword>
        <Keyword MajorTopicYN="N">MOMP</Keyword>
        <Keyword MajorTopicYN="N">antibiotic resistance</Keyword>
        <Keyword MajorTopicYN="N">efflux pump</Keyword>
        <Keyword MajorTopicYN="N">major outer membrane protein</Keyword>
        <Keyword MajorTopicYN="N">porin</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2013</Year>
          <Month>2</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2013</Year>
          <Month>2</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2013</Year>
          <Month>9</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">23406779</ArticleId>
        <ArticleId IdType="pmc">PMC3711981</ArticleId>
        <ArticleId IdType="doi">10.4161/viru.23753</ArticleId>
        <ArticleId IdType="pii">23753</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Zilbauer M, Dorrell N, Wren BW, Bajaj-Elliott M. Campylobacter jejuni-mediated disease pathogenesis: an update. Trans R Soc Trop Med Hyg. 2008;102:123–9. doi: 10.1016/j.trstmh.2007.09.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.trstmh.2007.09.019</ArticleId>
            <ArticleId IdType="pubmed">18023831</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eurosurveillance editorial team  The European Union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2010. Euro Surveill. 2012;17:20113.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22433599</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>EFSA  The Community Summary Report on antimicrobial resistance in zoonotic and indicator bacteria from animals and food in the European Union in 2008. Eur Food Safety Auth J. 2010;8:1658–919.</Citation>
        </Reference>
        <Reference>
          <Citation>OzFoodNet Working Group  Monitoring the incidence and causes of diseases potentially transmitted by food in Australia: annual report of the OzFoodNet Network, 2009. Commun Dis Intell. 2010;34:396–426.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21413526</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Notifiable and Other Diseases in New Zealand. Annula Report 2011. In: The Institute of Environmental Science and Research Ltd. Porirua, New Zealand; 2012.</Citation>
        </Reference>
        <Reference>
          <Citation>Allos BM, Blaser MJ. Campylobacter jejuni and related species. In: Mandell, ed. Principles and Practice of Infectious Diseases. Philadelphia: Churchill Livingstone; 2010:2793-802.</Citation>
        </Reference>
        <Reference>
          <Citation>Blaser MJ, Taylor DN, Feldman RA. Epidemiology of Campylobacter jejuni infections. Epidemiol Rev. 1983;5:157–76.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6357819</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention (CDC)  Incidence of foodborne illnesses: preliminary data from the Foodborne Diseases Active Surveillance Network (FoodNet)--United States, 1998. MMWR Morb Mortal Wkly Rep. 1999;48:189–94.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10208124</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>FoodNet - Foodborne Diseases Active Surveillance Network. Centers for Disease Control and Prevention, 2012. (Accessed March 14, 2012, at http://www.cdc.gov/foodnet/)</Citation>
        </Reference>
        <Reference>
          <Citation>Thomas C, Gibson H, Hill DJ, Mabey M. Campylobacter epidemiology: an aquatic perspective. J Appl Microbiol. 1998;85(Suppl 1):168S–77S. doi: 10.1111/j.1365-2672.1998.tb05296.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2672.1998.tb05296.x</ArticleId>
            <ArticleId IdType="pubmed">21182706</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Endtz HP, Ruijs GJ, van Klingeren B, Jansen WH, van der Reyden T, Mouton RP. Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. J Antimicrob Chemother. 1991;27:199–208. doi: 10.1093/jac/27.2.199.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/27.2.199</ArticleId>
            <ArticleId IdType="pubmed">2055811</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gupta A, Nelson JM, Barrett TJ, Tauxe RV, Rossiter SP, Friedman CR, et al. NARMS Working Group  Antimicrobial resistance among Campylobacter strains, United States, 1997-2001. Emerg Infect Dis. 2004;10:1102–9. doi: 10.3201/eid1006.030635.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid1006.030635</ArticleId>
            <ArticleId IdType="pmc">PMC3323172</ArticleId>
            <ArticleId IdType="pubmed">15207064</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luangtongkum T, Jeon B, Han J, Plummer P, Logue CM, Zhang Q. Antibiotic resistance in Campylobacter: emergence, transmission and persistence. Future Microbiol. 2009;4:189–200. doi: 10.2217/17460913.4.2.189.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2217/17460913.4.2.189</ArticleId>
            <ArticleId IdType="pmc">PMC2691575</ArticleId>
            <ArticleId IdType="pubmed">19257846</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith KE, Besser JM, Hedberg CW, Leano FT, Bender JB, Wicklund JH, et al. Investigation Team  Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. N Engl J Med. 1999;340:1525–32. doi: 10.1056/NEJM199905203402001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJM199905203402001</ArticleId>
            <ArticleId IdType="pubmed">10332013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Threlfall EJ, Ward LR, Frost JA, Willshaw GA. Spread of resistance from food animals to man--the UK experience. Acta Vet Scand Suppl. 2000;93:63–8, discussion 68-74.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10822859</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Boven M, Veldman KT, de Jong MC, Mevius DJ. Rapid selection of quinolone resistance in Campylobacter jejuni but not in Escherichia coli in individually housed broilers. J Antimicrob Chemother. 2003;52:719–23. doi: 10.1093/jac/dkg402.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/dkg402</ArticleId>
            <ArticleId IdType="pubmed">12951353</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hooper DC. Emerging mechanisms of fluoroquinolone resistance. Emerg Infect Dis. 2001;7:337–41. doi: 10.3201/eid0702.010239.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid0702.010239</ArticleId>
            <ArticleId IdType="pmc">PMC2631735</ArticleId>
            <ArticleId IdType="pubmed">11294736</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moore JE, Barton MD, Blair IS, Corcoran D, Dooley JS, Fanning S, et al.  The epidemiology of antibiotic resistance in Campylobacter. Microbes Infect. 2006;8:1955–66. doi: 10.1016/j.micinf.2005.12.030.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.micinf.2005.12.030</ArticleId>
            <ArticleId IdType="pubmed">16716632</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kittl S, Kuhnert P, Hächler H, Korczak BM. Comparison of genotypes and antibiotic resistance of Campylobacter jejuni isolated from humans and slaughtered chickens in Switzerland. J Appl Microbiol. 2011;110:513–20. doi: 10.1111/j.1365-2672.2010.04906.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2672.2010.04906.x</ArticleId>
            <ArticleId IdType="pubmed">21143711</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Monitoring antimicrobial usage in food animals for the protection of human health: Report of a WHO consultation. World Health Organization Department of Communicable Disease, Surveillance and Response 2001.</Citation>
        </Reference>
        <Reference>
          <Citation>Guerrant RL, Van Gilder T, Steiner TS, Thielman NM, Slutsker L, Tauxe RV, et al. Infectious Diseases Society of America  Practice guidelines for the management of infectious diarrhea. Clin Infect Dis. 2001;32:331–51. doi: 10.1086/318514.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/318514</ArticleId>
            <ArticleId IdType="pubmed">11170940</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sarmah AK, Meyer MT, Boxall AB. A global perspective on the use, sales, exposure pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in the environment. Chemosphere. 2006;65:725–59. doi: 10.1016/j.chemosphere.2006.03.026.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.chemosphere.2006.03.026</ArticleId>
            <ArticleId IdType="pubmed">16677683</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Council regulation (EC) No. 2821/98 of 17 December 1998 amending, as regards withdrawal of the authorization of certain antibiotics, Directive 70/524/EEC concerning additives in feedingstuffs. Official Journal of the European Communities. 1998;351:4–8.</Citation>
        </Reference>
        <Reference>
          <Citation>Ansary A, Radu S. Conjugal transfer of antibiotic resistances and plasmids from Campylobacter jejuni clinical isolates. FEMS Microbiol Lett. 1992;70:125–8. doi: 10.1111/j.1574-6968.1992.tb05196.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1574-6968.1992.tb05196.x</ArticleId>
            <ArticleId IdType="pubmed">1587459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bradbury WC, Munroe DL. Occurrence of plasmids and antibiotic resistance among Campylobacter jejuni and Campylobacter coli isolated from healthy and diarrheic animals. J Clin Microbiol. 1985;22:339–46.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC268406</ArticleId>
            <ArticleId IdType="pubmed">4044793</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gibreel A, Sköld O. High-level resistance to trimethoprim in clinical isolates of Campylobacter jejuni by acquisition of foreign genes (dfr1 and dfr9) expressing drug-insensitive dihydrofolate reductases. Antimicrob Agents Chemother. 1998;42:3059–64.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC105999</ArticleId>
            <ArticleId IdType="pubmed">9835491</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gibreel A, Sköld O, Taylor DE. Characterization of plasmid-mediated aphA-3 kanamycin resistance in Campylobacter jejuni. Microb Drug Resist. 2004;10:98–105. doi: 10.1089/1076629041310127.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/1076629041310127</ArticleId>
            <ArticleId IdType="pubmed">15256024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gibreel A, Tracz DM, Nonaka L, Ngo TM, Connell SR, Taylor DE. Incidence of antibiotic resistance in Campylobacter jejuni isolated in Alberta, Canada, from 1999 to 2002, with special reference to tet(O)-mediated tetracycline resistance. Antimicrob Agents Chemother. 2004;48:3442–50. doi: 10.1128/AAC.48.9.3442-3450.2004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.48.9.3442-3450.2004</ArticleId>
            <ArticleId IdType="pmc">PMC514748</ArticleId>
            <ArticleId IdType="pubmed">15328109</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lambert T, Gerbaud G, Trieu-Cuot P, Courvalin P. Structural relationship between the genes encoding 3′-aminoglycoside phosphotransferases in Campylobacter and in gram-positive cocci. Ann Inst Pasteur Microbiol. 1985;136B:135–50. doi: 10.1016/S0769-2609(85)80040-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0769-2609(85)80040-5</ArticleId>
            <ArticleId IdType="pubmed">3002237</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee MD, Sanchez S, Zimmer M, Idris U, Berrang ME, McDermott PF. Class 1 integron-associated tobramycin-gentamicin resistance in Campylobacter jejuni isolated from the broiler chicken house environment. Antimicrob Agents Chemother. 2002;46:3660–4. doi: 10.1128/AAC.46.11.3660-3664.2002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.46.11.3660-3664.2002</ArticleId>
            <ArticleId IdType="pmc">PMC128761</ArticleId>
            <ArticleId IdType="pubmed">12384387</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nirdnoy W, Mason CJ, Guerry P. Mosaic structure of a multiple-drug-resistant, conjugative plasmid from Campylobacter jejuni. Antimicrob Agents Chemother. 2005;49:2454–9. doi: 10.1128/AAC.49.6.2454-2459.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.49.6.2454-2459.2005</ArticleId>
            <ArticleId IdType="pmc">PMC1140535</ArticleId>
            <ArticleId IdType="pubmed">15917546</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Halloran F, Lucey B, Cryan B, Buckley T, Fanning S. Molecular characterization of class 1 integrons from Irish thermophilic Campylobacter spp. J Antimicrob Chemother. 2004;53:952–7. doi: 10.1093/jac/dkh193.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/dkh193</ArticleId>
            <ArticleId IdType="pubmed">15128721</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pinto-Alphandary H, Mabilat C, Courvalin P. Emergence of aminoglycoside resistance genes aadA and aadE in the genus Campylobacter. Antimicrob Agents Chemother. 1990;34:1294–6. doi: 10.1128/AAC.34.6.1294.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.34.6.1294</ArticleId>
            <ArticleId IdType="pmc">PMC171807</ArticleId>
            <ArticleId IdType="pubmed">2168151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sagara H, Mochizuki A, Okamura N, Nakaya R. Antimicrobial resistance of Campylobacter jejuni and Campylobacter coli with special reference to plasmid profiles of Japanese clinical isolates. Antimicrob Agents Chemother. 1987;31:713–9. doi: 10.1128/AAC.31.5.713.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.31.5.713</ArticleId>
            <ArticleId IdType="pmc">PMC174820</ArticleId>
            <ArticleId IdType="pubmed">3038005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Velázquez JB, Jiménez A, Chomón B, Villa TG. Incidence and transmission of antibiotic resistance in Campylobacter jejuni and Campylobacter coli. J Antimicrob Chemother. 1995;35:173–8. doi: 10.1093/jac/35.1.173.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/35.1.173</ArticleId>
            <ArticleId IdType="pubmed">7768766</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin J, Michel LO, Zhang Q. CmeABC functions as a multidrug efflux system in Campylobacter jejuni. Antimicrob Agents Chemother. 2002;46:2124–31. doi: 10.1128/AAC.46.7.2124-2131.2002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.46.7.2124-2131.2002</ArticleId>
            <ArticleId IdType="pmc">PMC127319</ArticleId>
            <ArticleId IdType="pubmed">12069964</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pumbwe L, Piddock LJ. Identification and molecular characterisation of CmeB, a Campylobacter jejuni multidrug efflux pump. FEMS Microbiol Lett. 2002;206:185–9. doi: 10.1111/j.1574-6968.2002.tb11007.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1574-6968.2002.tb11007.x</ArticleId>
            <ArticleId IdType="pubmed">11814661</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin J, Sahin O, Michel LO, Zhang Q. Critical role of multidrug efflux pump CmeABC in bile resistance and in vivo colonization of Campylobacter jejuni. Infect Immun. 2003;71:4250–9. doi: 10.1128/IAI.71.8.4250-4259.2003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.71.8.4250-4259.2003</ArticleId>
            <ArticleId IdType="pmc">PMC165992</ArticleId>
            <ArticleId IdType="pubmed">12874300</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Akiba M, Lin J, Barton YW, Zhang Q. Interaction of CmeABC and CmeDEF in conferring antimicrobial resistance and maintaining cell viability in Campylobacter jejuni. J Antimicrob Chemother. 2006;57:52–60. doi: 10.1093/jac/dki419.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/dki419</ArticleId>
            <ArticleId IdType="pubmed">16303882</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jeon B, Wang Y, Hao H, Barton YW, Zhang Q. Contribution of CmeG to antibiotic and oxidative stress resistance in Campylobacter jejuni. J Antimicrob Chemother. 2011;66:79–85. doi: 10.1093/jac/dkq418.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/dkq418</ArticleId>
            <ArticleId IdType="pmc">PMC3001851</ArticleId>
            <ArticleId IdType="pubmed">21081547</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parkhill J, Wren BW, Mungall K, Ketley JM, Churcher C, Basham D, et al.  The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature. 2000;403:665–8. doi: 10.1038/35001088.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/35001088</ArticleId>
            <ArticleId IdType="pubmed">10688204</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Corcoran D, Quinn T, Cotter L, Fanning S. An investigation of the molecular mechanisms contributing to high-level erythromycin resistance in Campylobacter. Int J Antimicrob Agents. 2006;27:40–5. doi: 10.1016/j.ijantimicag.2005.08.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijantimicag.2005.08.019</ArticleId>
            <ArticleId IdType="pubmed">16318913</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kurincic M, Botteldoorn N, Herman L, Smole Mozina S. Mechanisms of erythromycin resistance of Campylobacter spp. isolated from food, animals and humans. Int J Food Microbiol. 2007;120:186–90. doi: 10.1016/j.ijfoodmicro.2007.03.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijfoodmicro.2007.03.012</ArticleId>
            <ArticleId IdType="pubmed">17889390</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pumbwe L, Randall LP, Woodward MJ, Piddock LJ. Expression of the efflux pump genes cmeB, cmeF and the porin gene porA in multiple-antibiotic-resistant Campylobacter jejuni. J Antimicrob Chemother. 2004;54:341–7. doi: 10.1093/jac/dkh331.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/dkh331</ArticleId>
            <ArticleId IdType="pubmed">15201231</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Page WJ, Huyer G, Huyer M, Worobec EA. Characterization of the porins of Campylobacter jejuni and Campylobacter coli and implications for antibiotic susceptibility. Antimicrob Agents Chemother. 1989;33:297–303. doi: 10.1128/AAC.33.3.297.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.33.3.297</ArticleId>
            <ArticleId IdType="pmc">PMC171482</ArticleId>
            <ArticleId IdType="pubmed">2543277</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jeon B, Muraoka W, Scupham A, Zhang Q. Roles of lipooligosaccharide and capsular polysaccharide in antimicrobial resistance and natural transformation of Campylobacter jejuni. J Antimicrob Chemother. 2009;63:462–8. doi: 10.1093/jac/dkn529.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/dkn529</ArticleId>
            <ArticleId IdType="pmc">PMC2640156</ArticleId>
            <ArticleId IdType="pubmed">19147521</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karmali MA, De Grandis S, Fleming PC. Antimicrobial susceptibility of Campylobacter jejuni with special reference to resistance patterns of Canadian isolates. Antimicrob Agents Chemother. 1981;19:593–7. doi: 10.1128/AAC.19.4.593.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.19.4.593</ArticleId>
            <ArticleId IdType="pmc">PMC181484</ArticleId>
            <ArticleId IdType="pubmed">7247381</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Keo T, Collins J, Kunwar P, Blaser MJ, Iovine NM. Campylobacter capsule and lipooligosaccharide confer resistance to serum and cationic antimicrobials. Virulence. 2011;2:30–40. doi: 10.4161/viru.2.1.14752.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/viru.2.1.14752</ArticleId>
            <ArticleId IdType="pmc">PMC3073237</ArticleId>
            <ArticleId IdType="pubmed">21266840</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taylor DE, Ng LK, Lior H. Susceptibility of Campylobacter species to nalidixic acid, enoxacin, and other DNA gyrase inhibitors. Antimicrob Agents Chemother. 1985;28:708–10. doi: 10.1128/AAC.28.5.708.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.28.5.708</ArticleId>
            <ArticleId IdType="pmc">PMC176366</ArticleId>
            <ArticleId IdType="pubmed">3004325</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Mourik A, Steeghs L, van Laar J, Meiring HD, Hamstra HJ, van Putten JP, et al.  Altered linkage of hydroxyacyl chains in lipid A of Campylobacter jejuni reduces TLR4 activation and antimicrobial resistance. J Biol Chem. 2010;285:15828–36. doi: 10.1074/jbc.M110.102061.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M110.102061</ArticleId>
            <ArticleId IdType="pmc">PMC2871450</ArticleId>
            <ArticleId IdType="pubmed">20351099</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Akhtar SQ. Antimicrobial sensitivity and plasmid-mediated tetracycline resistance in Campylobacter jejuni isolated in Bangladesh. Chemotherapy. 1988;34:326–31. doi: 10.1159/000238587.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000238587</ArticleId>
            <ArticleId IdType="pubmed">3208549</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boonmar S, Sangsuk L, Suthivarakom K, Padungtod P, Morita Y. Serotypes and antimicrobial resistance of Campylobacter jejuni isolated from humans and animals in Thailand. Southeast Asian J Trop Med Public Health. 2005;36:130–4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15906655</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoge CW, Gambel JM, Srijan A, Pitarangsi C, Echeverria P. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clin Infect Dis. 1998;26:341–5. doi: 10.1086/516303.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/516303</ArticleId>
            <ArticleId IdType="pubmed">9502453</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS). Human Isolates Final Report, 2010. U.S. Department of Health and Human Services, CDC, 2012. (Accessed at http://www.cdc.gov/narms/reports.htm)</Citation>
        </Reference>
        <Reference>
          <Citation>DANMAP. 2011. Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark. In: The Danish Integrated Antimicrobial Resistance Monitoring and Research Programme; 2012.</Citation>
        </Reference>
        <Reference>
          <Citation>Van Looveren M, Daube G, De Zutter L, Dumont JM, Lammens C, Wijdooghe M, et al.  Antimicrobial susceptibilities of Campylobacter strains isolated from food animals in Belgium. J Antimicrob Chemother. 2001;48:235–40. doi: 10.1093/jac/48.2.235.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/48.2.235</ArticleId>
            <ArticleId IdType="pubmed">11481294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davidson D. In the matter of enrofloxacin for poultry: Withdrawal of approval of Bayer Corporation's new animal drug application 1 (NADA) 140-828 (Baytril). In: FDA Docket No 00N-1571 2004; 2004.</Citation>
        </Reference>
        <Reference>
          <Citation>Miflin JK, Templeton JM, Blackall PJ. Antibiotic resistance in Campylobacter jejuni and Campylobacter coli isolated from poultry in the South-East Queensland region. J Antimicrob Chemother. 2007;59:775–8. doi: 10.1093/jac/dkm024.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/dkm024</ArticleId>
            <ArticleId IdType="pubmed">17392353</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Unicomb LE, Ferguson J, Stafford RJ, Ashbolt R, Kirk MD, Becker NG, et al. Australian Campylobacter Subtyping Study Group  Low-level fluoroquinolone resistance among Campylobacter jejuni isolates in Australia. Clin Infect Dis. 2006;42:1368–74. doi: 10.1086/503426.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/503426</ArticleId>
            <ArticleId IdType="pubmed">16619147</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Norström M, Hofshagen M, Stavnes T, Schau J, Lassen J, Kruse H. Antimicrobial resistance in Campylobacter jejuni from humans and broilers in Norway. Epidemiol Infect. 2006;134:127–30. doi: 10.1017/S0950268805004814.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/S0950268805004814</ArticleId>
            <ArticleId IdType="pmc">PMC2870368</ArticleId>
            <ArticleId IdType="pubmed">16409659</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jain D, Sinha S, Prasad KN, Pandey CM. Campylobacter species and drug resistance in a north Indian rural community. Trans R Soc Trop Med Hyg. 2005;99:207–14. doi: 10.1016/j.trstmh.2004.09.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.trstmh.2004.09.006</ArticleId>
            <ArticleId IdType="pubmed">15653123</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bester LA, Essack SY. Observational study of the prevalence and antibiotic resistance of Campylobacter spp. from different poultry production systems in KwaZulu-Natal, South Africa. J Food Prot. 2012;75:154–9. doi: 10.4315/0362-028X.JFP-11-237.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4315/0362-028X.JFP-11-237</ArticleId>
            <ArticleId IdType="pubmed">22221370</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chokboonmongkol C, Patchanee P, Gölz G, Zessin KH, Alter T. Prevalence, quantitative load, and antimicrobial resistance of Campylobacter spp. from broiler ceca and broiler skin samples in Thailand. Poult Sci. 2013;92:462–7. doi: 10.3382/ps.2012-02599.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3382/ps.2012-02599</ArticleId>
            <ArticleId IdType="pubmed">23300314</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haruna M, Sasaki Y, Murakami M, Ikeda A, Kusukawa M, Tsujiyama Y, et al.  Prevalence and antimicrobial susceptibility of Campylobacter in broiler flocks in Japan. Zoonoses Public Health. 2012;59:241–5. doi: 10.1111/j.1863-2378.2011.01441.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1863-2378.2011.01441.x</ArticleId>
            <ArticleId IdType="pubmed">22103704</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wardak S, Szych J, Zasada AA, Gierczynski R. Antibiotic resistance of Campylobacter jejuni and Campylobacter coli clinical isolates from Poland. Antimicrob Agents Chemother. 2007;51:1123–5. doi: 10.1128/AAC.01187-06.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.01187-06</ArticleId>
            <ArticleId IdType="pmc">PMC1803138</ArticleId>
            <ArticleId IdType="pubmed">17210776</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sáenz Y, Zarazaga M, Lantero M, Gastanares MJ, Baquero F, Torres C. Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998. Antimicrob Agents Chemother. 2000;44:267–71. doi: 10.1128/AAC.44.2.267-271.2000.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.44.2.267-271.2000</ArticleId>
            <ArticleId IdType="pmc">PMC89669</ArticleId>
            <ArticleId IdType="pubmed">10639348</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Griggs DJ, Johnson MM, Frost JA, Humphrey T, Jørgensen F, Piddock LJ. Incidence and mechanism of ciprofloxacin resistance in Campylobacter spp. isolated from commercial poultry flocks in the United Kingdom before, during, and after fluoroquinolone treatment. Antimicrob Agents Chemother. 2005;49:699–707. doi: 10.1128/AAC.49.2.699-707.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.49.2.699-707.2005</ArticleId>
            <ArticleId IdType="pmc">PMC547197</ArticleId>
            <ArticleId IdType="pubmed">15673754</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Price LB, Johnson E, Vailes R, Silbergeld E. Fluoroquinolone-resistant Campylobacter isolates from conventional and antibiotic-free chicken products. Environ Health Perspect. 2005;113:557–60. doi: 10.1289/ehp.7647.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1289/ehp.7647</ArticleId>
            <ArticleId IdType="pmc">PMC1257547</ArticleId>
            <ArticleId IdType="pubmed">15866763</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Price LB, Lackey LG, Vailes R, Silbergeld E. The persistence of fluoroquinolone-resistant Campylobacter in poultry production. Environ Health Perspect. 2007;115:1035–9. doi: 10.1289/ehp.10050.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1289/ehp.10050</ArticleId>
            <ArticleId IdType="pmc">PMC1913601</ArticleId>
            <ArticleId IdType="pubmed">17637919</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Q, Lin J, Pereira S. Fluoroquinolone-resistant Campylobacter in animal reservoirs: dynamics of development, resistance mechanisms and ecological fitness. Anim Health Res Rev. 2003;4:63–71. doi: 10.1079/AHR200356.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1079/AHR200356</ArticleId>
            <ArticleId IdType="pubmed">15134291</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luo N, Pereira S, Sahin O, Lin J, Huang S, Michel L, et al.  Enhanced in vivo fitness of fluoroquinolone-resistant Campylobacter jejuni in the absence of antibiotic selection pressure. Proc Natl Acad Sci U S A. 2005;102:541–6. doi: 10.1073/pnas.0408966102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0408966102</ArticleId>
            <ArticleId IdType="pmc">PMC545549</ArticleId>
            <ArticleId IdType="pubmed">15634738</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ge B, McDermott PF, White DG, Meng J. Role of efflux pumps and topoisomerase mutations in fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother. 2005;49:3347–54. doi: 10.1128/AAC.49.8.3347-3354.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.49.8.3347-3354.2005</ArticleId>
            <ArticleId IdType="pmc">PMC1196287</ArticleId>
            <ArticleId IdType="pubmed">16048946</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luo N, Sahin O, Lin J, Michel LO, Zhang Q. In vivo selection of Campylobacter isolates with high levels of fluoroquinolone resistance associated with gyrA mutations and the function of the CmeABC efflux pump. Antimicrob Agents Chemother. 2003;47:390–4. doi: 10.1128/AAC.47.1.390-394.2003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.47.1.390-394.2003</ArticleId>
            <ArticleId IdType="pmc">PMC148968</ArticleId>
            <ArticleId IdType="pubmed">12499221</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yan M, Sahin O, Lin J, Zhang Q. Role of the CmeABC efflux pump in the emergence of fluoroquinolone-resistant Campylobacter under selection pressure. J Antimicrob Chemother. 2006;58:1154–9. doi: 10.1093/jac/dkl412.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/dkl412</ArticleId>
            <ArticleId IdType="pubmed">17023497</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drlica K, Zhao X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev. 1997;61:377–92.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC232616</ArticleId>
            <ArticleId IdType="pubmed">9293187</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shea ME, Hiasa H. Interactions between DNA helicases and frozen topoisomerase IV-quinolone-DNA ternary complexes. J Biol Chem. 1999;274:22747–54. doi: 10.1074/jbc.274.32.22747.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.274.32.22747</ArticleId>
            <ArticleId IdType="pubmed">10428858</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Willmott CJ, Critchlow SE, Eperon IC, Maxwell A. The complex of DNA gyrase and quinolone drugs with DNA forms a barrier to transcription by RNA polymerase. J Mol Biol. 1994;242:351–63. doi: 10.1006/jmbi.1994.1586.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1006/jmbi.1994.1586</ArticleId>
            <ArticleId IdType="pubmed">7932695</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bachoual R, Ouabdesselam S, Mory F, Lascols C, Soussy CJ, Tankovic J. Single or double mutational alterations of gyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli. Microb Drug Resist. 2001;7:257–61. doi: 10.1089/10766290152652800.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/10766290152652800</ArticleId>
            <ArticleId IdType="pubmed">11759087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cooper R, Segal H, Lastovica AJ, Elisha BG. Genetic basis of quinolone resistance and epidemiology of resistant and susceptible isolates of porcine Campylobacter coli strains. J Appl Microbiol. 2002;93:241–9. doi: 10.1046/j.1365-2672.2002.01650.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1365-2672.2002.01650.x</ArticleId>
            <ArticleId IdType="pubmed">12147072</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Payot S, Cloeckaert A, Chaslus-Dancla E. Selection and characterization of fluoroquinolone-resistant mutants of Campylobacter jejuni using enrofloxacin. Microb Drug Resist. 2002;8:335–43. doi: 10.1089/10766290260469606.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/10766290260469606</ArticleId>
            <ArticleId IdType="pubmed">12523631</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gootz TD, Martin BA. Characterization of high-level quinolone resistance in Campylobacter jejuni. Antimicrob Agents Chemother. 1991;35:840–5. doi: 10.1128/AAC.35.5.840.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.35.5.840</ArticleId>
            <ArticleId IdType="pmc">PMC245117</ArticleId>
            <ArticleId IdType="pubmed">1649570</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jesse TW, Englen MD, Pittenger-Alley LG, Fedorka-Cray PJ. Two distinct mutations in gyrA lead to ciprofloxacin and nalidixic acid resistance in Campylobacter coli and Campylobacter jejuni isolated from chickens and beef cattle. J Appl Microbiol. 2006;100:682–8. doi: 10.1111/j.1365-2672.2005.02796.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2672.2005.02796.x</ArticleId>
            <ArticleId IdType="pubmed">16553723</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Farnell MB, Donoghue AM, Cole K, Reyes-Herrera I, Blore PJ, Donoghue DJ. Campylobacter susceptibility to ciprofloxacin and corresponding fluoroquinolone concentrations within the gastrointestinal tracts of chickens. J Appl Microbiol. 2005;99:1043–50. doi: 10.1111/j.1365-2672.2005.02712.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2672.2005.02712.x</ArticleId>
            <ArticleId IdType="pubmed">16238734</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McDermott PF, Bodeis SM, English LL, White DG, Walker RD, Zhao S, et al.  Ciprofloxacin resistance in Campylobacter jejuni evolves rapidly in chickens treated with fluoroquinolones. J Infect Dis. 2002;185:837–40. doi: 10.1086/339195.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/339195</ArticleId>
            <ArticleId IdType="pubmed">11920303</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takahashi T, Ishihara K, Kojima A, Asai T, Harada K, Tamura Y. Emergence of fluoroquinolone resistance in Campylobacter jejuni in chickens exposed to enrofloxacin treatment at the inherent dosage licensed in Japan. J Vet Med B Infect Dis Vet Public Health. 2005;52:460–4. doi: 10.1111/j.1439-0450.2005.00890.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1439-0450.2005.00890.x</ArticleId>
            <ArticleId IdType="pubmed">16364022</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ellis-Pegler RB, Hyman LK, Ingram RJ, McCarthy M. A placebo controlled evaluation of lomefloxacin in the treatment of bacterial diarrhoea in the community. J Antimicrob Chemother. 1995;36:259–63. doi: 10.1093/jac/36.1.259.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/36.1.259</ArticleId>
            <ArticleId IdType="pubmed">8537277</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Segreti J, Gootz TD, Goodman LJ, Parkhurst GW, Quinn JP, Martin BA, et al.  High-level quinolone resistance in clinical isolates of Campylobacter jejuni. J Infect Dis. 1992;165:667–70. doi: 10.1093/infdis/165.4.667.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/165.4.667</ArticleId>
            <ArticleId IdType="pubmed">1313069</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wretlind B, Strömberg A, Ostlund L, Sjögren E, Kaijser B. Rapid emergence of quinolone resistance in Campylobacter jejuni in patients treated with norfloxacin. Scand J Infect Dis. 1992;24:685–6. doi: 10.3109/00365549209054659.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/00365549209054659</ArticleId>
            <ArticleId IdType="pubmed">1465591</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruiz J, Goñi P, Marco F, Gallardo F, Mirelis B, Jimenez De Anta T, et al.  Increased resistance to quinolones in Campylobacter jejuni: a genetic analysis of gyrA gene mutations in quinolone-resistant clinical isolates. Microbiol Immunol. 1998;42:223–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9580533</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Huang WM, Taylor DE. Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations. Antimicrob Agents Chemother. 1993;37:457–63. doi: 10.1128/AAC.37.3.457.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.37.3.457</ArticleId>
            <ArticleId IdType="pmc">PMC187693</ArticleId>
            <ArticleId IdType="pubmed">8384814</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Piddock LJ, Ricci V, Pumbwe L, Everett MJ, Griggs DJ. Fluoroquinolone resistance in Campylobacter species from man and animals: detection of mutations in topoisomerase genes. J Antimicrob Chemother. 2003;51:19–26. doi: 10.1093/jac/dkg033.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/dkg033</ArticleId>
            <ArticleId IdType="pubmed">12493783</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Engberg J, Neimann J, Nielsen EM, Aerestrup FM, Fussing V. Quinolone-resistant Campylobacter infections: risk factors and clinical consequences. Emerg Infect Dis. 2004;10:1056–63. doi: 10.3201/eid1006.030669.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid1006.030669</ArticleId>
            <ArticleId IdType="pmc">PMC3323146</ArticleId>
            <ArticleId IdType="pubmed">15207057</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feodoroff FB, Lauhio AR, Sarna SJ, Hänninen ML, Rautelin HI. Severe diarrhoea caused by highly ciprofloxacin-susceptible Campylobacter isolates. Clin Microbiol Infect. 2009;15:188–92. doi: 10.1111/j.1469-0691.2008.02657.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1469-0691.2008.02657.x</ArticleId>
            <ArticleId IdType="pubmed">19154485</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Helms M, Simonsen J, Olsen KE, Mølbak K. Adverse health events associated with antimicrobial drug resistance in Campylobacter species: a registry-based cohort study. J Infect Dis. 2005;191:1050–5. doi: 10.1086/428453.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/428453</ArticleId>
            <ArticleId IdType="pubmed">15747238</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nelson JM, Smith KE, Vugia DJ, Rabatsky-Ehr T, Segler SD, Kassenborg HD, et al.  Prolonged diarrhea due to ciprofloxacin-resistant campylobacter infection. J Infect Dis. 2004;190:1150–7. doi: 10.1086/423282.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/423282</ArticleId>
            <ArticleId IdType="pubmed">15319866</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sonnevend A, Kovács J, Pál T, Akawi N, Nagelkerke N, Schneider G. Lack of correlation between the 257C-to-T mutation in the gyrA gene and clinical severity of Campylobacter jejuni infection in a region of high incidence of ciprofloxacin resistance. Scand J Infect Dis. 2011;43:905–11. doi: 10.3109/00365548.2011.603743.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/00365548.2011.603743</ArticleId>
            <ArticleId IdType="pubmed">21905953</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wassenaar TM, Kist M, de Jong A. Re-analysis of the risks attributed to ciprofloxacin-resistant Campylobacter jejuni infections. Int J Antimicrob Agents. 2007;30:195–201. doi: 10.1016/j.ijantimicag.2007.01.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijantimicag.2007.01.019</ArticleId>
            <ArticleId IdType="pubmed">17420115</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Asai T, Harada K, Ishihara K, Kojima A, Sameshima T, Tamura Y, et al.  Association of antimicrobial resistance in Campylobacter isolated from food-producing animals with antimicrobial use on farms. Jpn J Infect Dis. 2007;60:290–4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17881869</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Animal Drugs @ FDA. Center for Veterinary Medicine, 2012. (Accessed at http://www.accessdata.fda.gov/scripts/animaldrugsatfda/index.cfm)</Citation>
        </Reference>
        <Reference>
          <Citation>Cagliero C, Mouline C, Cloeckaert A, Payot S. Synergy between efflux pump CmeABC and modifications in ribosomal proteins L4 and L22 in conferring macrolide resistance in Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother. 2006;50:3893–6. doi: 10.1128/AAC.00616-06.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.00616-06</ArticleId>
            <ArticleId IdType="pmc">PMC1635205</ArticleId>
            <ArticleId IdType="pubmed">16940070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin J, Yan M, Sahin O, Pereira S, Chang YJ, Zhang Q. Effect of macrolide usage on emergence of erythromycin-resistant Campylobacter isolates in chickens. Antimicrob Agents Chemother. 2007;51:1678–86. doi: 10.1128/AAC.01411-06.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.01411-06</ArticleId>
            <ArticleId IdType="pmc">PMC1855539</ArticleId>
            <ArticleId IdType="pubmed">17353243</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Payot S, Bolla JM, Corcoran D, Fanning S, Mégraud F, Zhang Q. Mechanisms of fluoroquinolone and macrolide resistance in Campylobacter spp. Microbes Infect. 2006;8:1967–71. doi: 10.1016/j.micinf.2005.12.032.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.micinf.2005.12.032</ArticleId>
            <ArticleId IdType="pubmed">16713726</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Egger R, Korczak BM, Niederer L, Overesch G, Kuhnert P. Genotypes and antibiotic resistance of Campylobacter coli in fattening pigs. Vet Microbiol. 2012;155:272–8. doi: 10.1016/j.vetmic.2011.08.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vetmic.2011.08.012</ArticleId>
            <ArticleId IdType="pubmed">21899961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gibreel A, Taylor DE. Macrolide resistance in Campylobacter jejuni and Campylobacter coli. J Antimicrob Chemother. 2006;58:243–55. doi: 10.1093/jac/dkl210.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/dkl210</ArticleId>
            <ArticleId IdType="pubmed">16735431</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lachance N, Gaudreau C, Lamothe F, Larivière LA. Role of the beta-lactamase of Campylobacter jejuni in resistance to beta-lactam agents. Antimicrob Agents Chemother. 1991;35:813–8. doi: 10.1128/AAC.35.5.813.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.35.5.813</ArticleId>
            <ArticleId IdType="pmc">PMC245112</ArticleId>
            <ArticleId IdType="pubmed">1854162</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lehtopolku M, Kotilainen P, Haanperä-Heikkinen M, Nakari UM, Hänninen ML, Huovinen P, et al.  Ribosomal mutations as the main cause of macrolide resistance in Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother. 2011;55:5939–41. doi: 10.1128/AAC.00314-11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.00314-11</ArticleId>
            <ArticleId IdType="pmc">PMC3232809</ArticleId>
            <ArticleId IdType="pubmed">21911571</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mamelli L, Prouzet-Mauléon V, Pagès JM, Mégraud F, Bolla JM. Molecular basis of macrolide resistance in Campylobacter: role of efflux pumps and target mutations. J Antimicrob Chemother. 2005;56:491–7. doi: 10.1093/jac/dki253.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/dki253</ArticleId>
            <ArticleId IdType="pubmed">16055509</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pérez-Boto D, López-Portolés JA, Simón C, Valdezate S, Echeita MA. Study of the molecular mechanisms involved in high-level macrolide resistance of Spanish Campylobacter jejuni and Campylobacter coli strains. J Antimicrob Chemother. 2010;65:2083–8. doi: 10.1093/jac/dkq268.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/dkq268</ArticleId>
            <ArticleId IdType="pubmed">20647243</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ren GW, Wang Y, Shen Z, Chen X, Shen J, Wu C. Rapid detection of point mutations in domain V of the 23S rRNA gene in erythromycin-resistant Campylobacter isolates by pyrosequencing. Foodborne Pathog Dis. 2011;8:375–9. doi: 10.1089/fpd.2010.0676.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/fpd.2010.0676</ArticleId>
            <ArticleId IdType="pubmed">21166562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vacher S, Menard A, Bernard E, Santos A, Megraud F. Detection of mutations associated with macrolide resistance in thermophilic Campylobacter spp. by real-time PCR. Microb Drug Resist. 2005;11:40–7. doi: 10.1089/mdr.2005.11.40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/mdr.2005.11.40</ArticleId>
            <ArticleId IdType="pubmed">15770093</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fouts DE, Mongodin EF, Mandrell RE, Miller WG, Rasko DA, Ravel J, et al.  Major structural differences and novel potential virulence mechanisms from the genomes of multiple campylobacter species. PLoS Biol. 2005;3:e15. doi: 10.1371/journal.pbio.0030015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pbio.0030015</ArticleId>
            <ArticleId IdType="pmc">PMC539331</ArticleId>
            <ArticleId IdType="pubmed">15660156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gibreel A, Wetsch NM, Taylor DE. Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni. Antimicrob Agents Chemother. 2007;51:3212–6. doi: 10.1128/AAC.01592-06.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.01592-06</ArticleId>
            <ArticleId IdType="pmc">PMC2043232</ArticleId>
            <ArticleId IdType="pubmed">17606685</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Payot S, Avrain L, Magras C, Praud K, Cloeckaert A, Chaslus-Dancla E. Relative contribution of target gene mutation and efflux to fluoroquinolone and erythromycin resistance, in French poultry and pig isolates of Campylobacter coli. Int J Antimicrob Agents. 2004;23:468–72. doi: 10.1016/j.ijantimicag.2003.12.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijantimicag.2003.12.008</ArticleId>
            <ArticleId IdType="pubmed">15120725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Logue CM, Danzeisen GT, Sherwood JS, Thorsness JL, Mercier BM, Axtman JE. Repeated therapeutic dosing selects macrolide-resistant Campylobacter spp. in a turkey facility. J Appl Microbiol. 2010;109:1379–88. doi: 10.1111/j.1365-2672.2010.04765.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2672.2010.04765.x</ArticleId>
            <ArticleId IdType="pubmed">20497488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Almofti YA, Dai M, Sun Y, Haihong H, Yuan Z. Impact of erythromycin resistance on the virulence properties and fitness of Campylobacter jejuni. Microb Pathog. 2011;50:336–42. doi: 10.1016/j.micpath.2011.02.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.micpath.2011.02.009</ArticleId>
            <ArticleId IdType="pubmed">21377522</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Han F, Pu S, Wang F, Meng J, Ge B. Fitness cost of macrolide resistance in Campylobacter jejuni. Int J Antimicrob Agents. 2009;34:462–6. doi: 10.1016/j.ijantimicag.2009.06.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijantimicag.2009.06.019</ArticleId>
            <ArticleId IdType="pubmed">19651494</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hao H, Dai M, Wang Y, Peng D, Liu Z, Yuan Z. 23S rRNA mutation A2074C conferring high-level macrolide resistance and fitness cost in Campylobacter jejuni. Microb Drug Resist. 2009;15:239–44. doi: 10.1089/mdr.2009.0008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/mdr.2009.0008</ArticleId>
            <ArticleId IdType="pubmed">19857128</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zeitouni S, Collin O, Andraud M, Ermel G, Kempf I. Fitness of macrolide resistant Campylobacter coli and Campylobacter jejuni. Microb Drug Resist. 2012;18:101–8. doi: 10.1089/mdr.2011.0188.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/mdr.2011.0188</ArticleId>
            <ArticleId IdType="pubmed">22324770</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>EFSA  The European Union Summary Report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2010. Eur Food Safety Auth J. 2012;10:2598–830.</Citation>
        </Reference>
        <Reference>
          <Citation>Smith SI, Sansa TI, Coker AO. Antibiotic susceptibility patterns and beta-lactamase production of animal and human isolates of Campylobacter in Lagos, Nigeria. Z Naturforsch C. 1999;54:583–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10488568</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gibreel A, Kos VN, Keelan M, Trieber CA, Levesque S, Michaud S, et al.  Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype. Antimicrob Agents Chemother. 2005;49:2753–9. doi: 10.1128/AAC.49.7.2753-2759.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.49.7.2753-2759.2005</ArticleId>
            <ArticleId IdType="pmc">PMC1168676</ArticleId>
            <ArticleId IdType="pubmed">15980346</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Caldwell DB, Wang Y, Lin J. Development, stability, and molecular mechanisms of macrolide resistance in Campylobacter jejuni. Antimicrob Agents Chemother. 2008;52:3947–54. doi: 10.1128/AAC.00450-08.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.00450-08</ArticleId>
            <ArticleId IdType="pmc">PMC2573100</ArticleId>
            <ArticleId IdType="pubmed">18779354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jeon B, Zhang Q. Sensitization of Campylobacter jejuni to fluoroquinolone and macrolide antibiotics by antisense inhibition of the CmeABC multidrug efflux transporter. J Antimicrob Chemother. 2009;63:946–8. doi: 10.1093/jac/dkp067.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/dkp067</ArticleId>
            <ArticleId IdType="pmc">PMC2667136</ArticleId>
            <ArticleId IdType="pubmed">19279049</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huyer MP, Hancock T, Page RW. Outer membrane porin protein of Campylobacter jejuni. FEMS Microbiol Lett. 1986;37:247–50. doi: 10.1111/j.1574-6968.1986.tb01803.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1574-6968.1986.tb01803.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hancock RE, Bell A. Antibiotic uptake into gram-negative bacteria. Eur J Clin Microbiol Infect Dis. 1988;7:713–20. doi: 10.1007/BF01975036.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF01975036</ArticleId>
            <ArticleId IdType="pubmed">2850910</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vaara M. Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria. Antimicrob Agents Chemother. 1993;37:354–6. doi: 10.1128/AAC.37.2.354.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.37.2.354</ArticleId>
            <ArticleId IdType="pmc">PMC187668</ArticleId>
            <ArticleId IdType="pubmed">8383945</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Logan SM, Trust TJ. Structural and antigenic heterogeneity of lipopolysaccharides of Campylobacter jejuni and Campylobacter coli. Infect Immun. 1984;45:210–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC263302</ArticleId>
            <ArticleId IdType="pubmed">6203838</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Naess V, Hofstad T. Isolation and chemical composition of lipopolysaccharide from Campylobacter jejuni. Acta Pathol Microbiol Immunol Scand B. 1982;90:135–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7080831</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giesbrecht P, Kersten T, Maidhof H, Wecke J. Staphylococcal cell wall: morphogenesis and fatal variations in the presence of penicillin. Microbiol Mol Biol Rev. 1998;62:1371–414.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC98950</ArticleId>
            <ArticleId IdType="pubmed">9841676</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alfredson DA, Korolik V. Isolation and expression of a novel molecular class D beta-lactamase, OXA-61, from Campylobacter jejuni. Antimicrob Agents Chemother. 2005;49:2515–8. doi: 10.1128/AAC.49.6.2515-2518.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.49.6.2515-2518.2005</ArticleId>
            <ArticleId IdType="pmc">PMC1140520</ArticleId>
            <ArticleId IdType="pubmed">15917560</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Griggs DJ, Peake L, Johnson MM, Ghori S, Mott A, Piddock LJ. Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni. Antimicrob Agents Chemother. 2009;53:3357–64. doi: 10.1128/AAC.01655-08.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.01655-08</ArticleId>
            <ArticleId IdType="pmc">PMC2715628</ArticleId>
            <ArticleId IdType="pubmed">19506058</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lachance N, Gaudreau C, Lamothe F, Turgeon F. Susceptibilities of beta-lactamase-positive and -negative strains of Campylobacter coli to beta-lactam agents. Antimicrob Agents Chemother. 1993;37:1174–6. doi: 10.1128/AAC.37.5.1174.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.37.5.1174</ArticleId>
            <ArticleId IdType="pmc">PMC187926</ArticleId>
            <ArticleId IdType="pubmed">8390812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tajada P, Gomez-Graces JL, Alós JI, Balas D, Cogollos R. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 beta-lactam agents and combinations with beta-lactamase inhibitors. Antimicrob Agents Chemother. 1996;40:1924–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC163441</ArticleId>
            <ArticleId IdType="pubmed">8843305</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wright EP, Knowles MA. Beta-lactamase production by Campylobacter jejuni. J Clin Pathol. 1980;33:904–5. doi: 10.1136/jcp.33.9.904-b.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jcp.33.9.904-b</ArticleId>
            <ArticleId IdType="pmc">PMC1146264</ArticleId>
            <ArticleId IdType="pubmed">6968758</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alfredson DA, Korolik V. Identification of putative zinc hydrolase genes of the metallo-beta-lactamase superfamily from Campylobacter jejuni. FEMS Immunol Med Microbiol. 2007;49:159–64. doi: 10.1111/j.1574-695X.2006.00197.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1574-695X.2006.00197.x</ArticleId>
            <ArticleId IdType="pubmed">17266723</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Potter ME, Blaser MJ, Sikes RK, Kaufmann AF, Wells JG. Human Campylobacter infection associated with certified raw milk. Am J Epidemiol. 1983;117:475–83.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6837559</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chopra I, Roberts M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev. 2001;65:232–60. doi: 10.1128/MMBR.65.2.232-260.2001. [second page, table of contents.]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/MMBR.65.2.232-260.2001</ArticleId>
            <ArticleId IdType="pmc">PMC99026</ArticleId>
            <ArticleId IdType="pubmed">11381101</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bolla JM, Loret E, Zalewski M, Pagés JM. Conformational analysis of the Campylobacter jejuni porin. J Bacteriol. 1995;177:4266–71.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC177172</ArticleId>
            <ArticleId IdType="pubmed">7543469</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kervella M, Fauchère JL, Fourel D, Pagès JM. Immunological cross-reactivity between outer membrane pore proteins of Campylobacter jejuni and Escherichia coli. FEMS Microbiol Lett. 1992;78:281–5. doi: 10.1111/j.1574-6968.1992.tb05582.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1574-6968.1992.tb05582.x</ArticleId>
            <ArticleId IdType="pubmed">1337053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Epe B, Woolley P, Hornig H. Competition between tetracycline and tRNA at both P and A sites of the ribosome of Escherichia coli. FEBS Lett. 1987;213:443–7. doi: 10.1016/0014-5793(87)81539-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0014-5793(87)81539-9</ArticleId>
            <ArticleId IdType="pubmed">3104093</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goldman RA, Hasan T, Hall CC, Strycharz WA, Cooperman BS. Photoincorporation of tetracycline into Escherichia coli ribosomes. Identification of the major proteins photolabeled by native tetracycline and tetracycline photoproducts and implications for the inhibitory action of tetracycline on protein synthesis. Biochemistry. 1983;22:359–68. doi: 10.1021/bi00271a020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/bi00271a020</ArticleId>
            <ArticleId IdType="pubmed">6337627</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manavathu EK, Hiratsuka K, Taylor DE. Nucleotide sequence analysis and expression of a tetracycline-resistance gene from Campylobacter jejuni. Gene. 1988;62:17–26. doi: 10.1016/0378-1119(88)90576-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0378-1119(88)90576-8</ArticleId>
            <ArticleId IdType="pubmed">2836268</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salyers AA, Speer BS, Shoemaker NB. New perspectives in tetracycline resistance. Mol Microbiol. 1990;4:151–6. doi: 10.1111/j.1365-2958.1990.tb02025.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2958.1990.tb02025.x</ArticleId>
            <ArticleId IdType="pubmed">2181236</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dasti JI, Gross U, Pohl S, Lugert R, Weig M, Schmidt-Ott R. Role of the plasmid-encoded tet(O) gene in tetracycline-resistant clinical isolates of Campylobacter jejuni and Campylobacter coli. J Med Microbiol. 2007;56:833–7. doi: 10.1099/jmm.0.47103-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/jmm.0.47103-0</ArticleId>
            <ArticleId IdType="pubmed">17510271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taylor DE. Plasmid-mediated tetracycline resistance in Campylobacter jejuni: expression in Escherichia coli and identification of homology with streptococcal class M determinant. J Bacteriol. 1986;165:1037–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC214536</ArticleId>
            <ArticleId IdType="pubmed">3005233</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Batchelor RA, Pearson BM, Friis LM, Guerry P, Wells JM. Nucleotide sequences and comparison of two large conjugative plasmids from different Campylobacter species. Microbiology. 2004;150:3507–17. doi: 10.1099/mic.0.27112-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/mic.0.27112-0</ArticleId>
            <ArticleId IdType="pubmed">15470128</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taylor DE, Courvalin P. Mechanisms of antibiotic resistance in Campylobacter species. Antimicrob Agents Chemother. 1988;32:1107–12. doi: 10.1128/AAC.32.8.1107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.32.8.1107</ArticleId>
            <ArticleId IdType="pmc">PMC172360</ArticleId>
            <ArticleId IdType="pubmed">3056250</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sahin O, Plummer PJ, Jordan DM, Sulaj K, Pereira S, Robbe-Austerman S, et al.  Emergence of a tetracycline-resistant Campylobacter jejuni clone associated with outbreaks of ovine abortion in the United States. J Clin Microbiol. 2008;46:1663–71. doi: 10.1128/JCM.00031-08.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.00031-08</ArticleId>
            <ArticleId IdType="pmc">PMC2395063</ArticleId>
            <ArticleId IdType="pubmed">18322054</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bérdy J. CRC handbook of antibiotic compounds. Boca Raton, Fla.: CRC Press; 1980.</Citation>
        </Reference>
        <Reference>
          <Citation>Jana S, Deb JK. Molecular understanding of aminoglycoside action and resistance. Appl Microbiol Biotechnol. 2006;70:140–50. doi: 10.1007/s00253-005-0279-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00253-005-0279-0</ArticleId>
            <ArticleId IdType="pubmed">16391922</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taber HW, Mueller JP, Miller PF, Arrow AS. Bacterial uptake of aminoglycoside antibiotics. Microbiol Rev. 1987;51:439–57.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC373126</ArticleId>
            <ArticleId IdType="pubmed">3325794</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bryan LE, Kwan S. Roles of ribosomal binding, membrane potential, and electron transport in bacterial uptake of streptomycin and gentamicin. Antimicrob Agents Chemother. 1983;23:835–45. doi: 10.1128/AAC.23.6.835.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.23.6.835</ArticleId>
            <ArticleId IdType="pmc">PMC184978</ArticleId>
            <ArticleId IdType="pubmed">6351731</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bryan LE, Van Den Elzen HM. Gentamicin accumulation by sensitive strains of Escherichia coli and Pseudomonas aeruginosa. J Antibiot (Tokyo) 1975;28:696–703. doi: 10.7164/antibiotics.28.696.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7164/antibiotics.28.696</ArticleId>
            <ArticleId IdType="pubmed">810469</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hermann T. Aminoglycoside antibiotics: old drugs and new therapeutic approaches. Cell Mol Life Sci. 2007;64:1841–52. doi: 10.1007/s00018-007-7034-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00018-007-7034-x</ArticleId>
            <ArticleId IdType="pubmed">17447006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ouellette M, Gerbaud G, Lambert T, Courvalin P. Acquisition by a Campylobacter-like strain of aphA-1, a kanamycin resistance determinant from members of the family Enterobacteriaceae. Antimicrob Agents Chemother. 1987;31:1021–6. doi: 10.1128/AAC.31.7.1021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.31.7.1021</ArticleId>
            <ArticleId IdType="pmc">PMC174865</ArticleId>
            <ArticleId IdType="pubmed">2821885</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tenover FC, Fennell CL, Lee L, LeBlanc DJ. Characterization of two plasmids from Campylobacter jejuni isolates that carry the aphA-7 kanamycin resistance determinant. Antimicrob Agents Chemother. 1992;36:712–6. doi: 10.1128/AAC.36.4.712.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.36.4.712</ArticleId>
            <ArticleId IdType="pmc">PMC189362</ArticleId>
            <ArticleId IdType="pubmed">1503433</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tenover FC, Filpula D, Phillips KL, Plorde JJ. Cloning and sequencing of a gene encoding an aminoglycoside 6′-N-acetyltransferase from an R factor of Citrobacter diversus. J Bacteriol. 1988;170:471–3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC210671</ArticleId>
            <ArticleId IdType="pubmed">2826403</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tenover FC, Gilbert T, O’Hara P. Nucleotide sequence of a novel kanamycin resistance gene, aphA-7, from Campylobacter jejuni and comparison to other kanamycin phosphotransferase genes. Plasmid. 1989;22:52–8. doi: 10.1016/0147-619X(89)90035-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0147-619X(89)90035-8</ArticleId>
            <ArticleId IdType="pubmed">2550983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olkkola S, Juntunen P, Heiska H, Hyytiäinen H, Hänninen ML. Mutations in the rpsL gene are involved in streptomycin resistance in Campylobacter coli. Microb Drug Resist. 2010;16:105–10. doi: 10.1089/mdr.2009.0128.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/mdr.2009.0128</ArticleId>
            <ArticleId IdType="pubmed">20370506</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hannula M, Hänninen ML. Effect of putative efflux pump inhibitors and inducers on the antimicrobial susceptibility of Campylobacter jejuni and Campylobacter coli. J Med Microbiol. 2008;57:851–5. doi: 10.1099/jmm.0.47823-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/jmm.0.47823-0</ArticleId>
            <ArticleId IdType="pubmed">18566143</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pumbwe L, Piddock LJV. Identification and molecular characterisation of CmeB, a Campylobacter jejuni multidrug efflux pump. FEMS Microbiol Lett. 2002;206:185–9. doi: 10.1111/j.1574-6968.2002.tb11007.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1574-6968.2002.tb11007.x</ArticleId>
            <ArticleId IdType="pubmed">11814661</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
